Pacira Biosciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
State Street Corporation has reported a beneficial ownership of 5.2% in Pacira Biosciences Inc. common stock as of June 30, 2026.
NASDAQ
Dimensional Fund Advisors LP has disclosed beneficial ownership of 5.1% of Pacira BioSciences Inc.'s common stock as of March 31, 2026.
NASDAQ
The Vanguard Group reported 0% beneficial ownership in Pacira BioSciences Inc. following an internal realignment.
NASDAQ
Renaissance Technologies LLC and its parent company have reported a 4.98% beneficial ownership in Pacira BioSciences, Inc. common stock.
NASDAQ
Renaissance Technologies LLC and its parent company, Renaissance Technologies Holdings Corporation, have disclosed a 5.34% beneficial ownership stake in Pacira BioSciences, Inc.
NASDAQ
Pacer US Small Cap Cash Cows ETF, Pacer US Small Cap Cash Cows Growth Leaders ETF, Pacer Advisors, Inc., and Joe M. Thomson have jointly filed an amended Schedule 13G, disclosing a combined passive beneficial ownership of 1.28% in Pacira BioSciences, Inc.
NASDAQ
Pacer US Small Cap Cash Cows ETF, Pacer Advisors, Inc., and Joe M. Thomson have jointly disclosed a beneficial ownership of 6.93% in Pacira BioSciences, Inc. as of December 31, 2024.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 15.2% of Pacira BioSciences, Inc.'s common stock as of March 31, 2025.
NASDAQ
Millennium Management LLC, along with its affiliates and Israel A. Englander, has filed an amended Schedule 13G disclosing a passive beneficial ownership of 0.7% in Pacira BioSciences, Inc.'s common stock as of March 31, 2025.
NASDAQ
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has reported a passive 5.1% beneficial ownership stake in Pacira BioSciences, Inc.